Please Wait.....
Report
Recombinant Cell Culture Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product (Recombinant Albumin, Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Transferrin, Recombinant Trypsin, Others), By Application (Regenerative Medicine v/s Bio-Production), By Expression System (Mammalian Expression System, E.Coli Expression System, Yeast Expression System, Others), By End User (Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others), and By Region
Market Report I 2022-12-01 I 119 Pages I TechSci Research
The global recombinant cell culture supplements market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing demand for animal free recombinant cell culture supplements and increase in investments in R&D are curbing the growth of the market. Cell culture is a process of removing cells from plant source or animal and rising subsequently under regulated conditions. Cell culture is an important technique used in the diagnostic laboratories, research institutes, pharmaceutical and biotechnology industries, for applications such as drug discovery, production, and diagnostic screening. The other factors supporting the market's growth are, rise in demand in cell culture projects, increasing government investments, growing number of mergers and strategic acquisitions, and technological advancements.
Rising Demand for Recombinant Cell Culture Supplements
Over the past few years, there is a surge in demand for recombinant cell culture supplements as cell culture is an essential part of manufacturing and drug research and development. It plays a vital role in enriching cell viability, providing a healthy culture, and customizing the cell culture in accordance with the requirements of the individual. Owing to various kinds of diseases such as infectious, communicable, non-infectious, chronic and others present across the world, the demand for variety of recombinant vaccines, advanced therapies, proteins, and biopharmaceuticals are rising. Furthermore, rising demand for stem cell therapy for clinical treatment of various diseases and growing patients acceptance are bolstering the growth of the market.
Increasing Investments and R&D Activities
Huge investments are invested on various R&D activities by governments and key market players, which strengthens the market growth. Manufactures are focusing on expanding the production, which is driving the growth of the market. For instance, in 2019, FUJIFILM Irvine Scientific announced the construction of new cell culture production bases in Europe and Netherlands. The increasing investments and manufacturing capacity expansion is fueling the growth of the market. Recombinant cell culture supplements are a crucial part of cancer research. Therefore, rising R&D activities in oncology and stem cell research is propelling the growth of the market. Pharmaceutical and biotechnology companies majorly focus on research and development (R&D) activities in the life science sector, which is augmenting the growth of the market. In the U.S, the revenue in Scientific Research & Development is anticipated to amount to USD 8.11 billion by the end of 2022.
Increasing Demand for Animal-Free Recombinant Cell Culture Supplements
Owing to the rising demand of animal free products, manufacturers are focusing on animal-free recombinant cell culture supplements. The surge in demand is attributed to the various factors such as they are manufactured using all human production system, it eliminates the risk of contamination, and no animals derived cells are used. Animal free recombinant cell culture supplements are free of any animal elements such as endotoxin, serum, and others. Moreover, animal-free growth factors & recombinant cell culture supplements are obtaining high acceptance in various research applications, which is fostering the growth of the market, globally.
Market Segmentation
The global recombinant cell culture supplements market is segmented into product, application, expression system, end user and company. Based on product, the market is divided into recombinant albumin, recombinant insulin, recombinant epidermal growth factors, recombinant transferrin, recombinant trypsin, and others. Based on application, the market is divided into regenerative medicine and bio-production. Based on regenerative medicine, the market is further segmented into stem cell therapies, cell therapies, and gene therapies. Based on bio-production, the market is further divides into monoclonal antibodies, recombinant proteins, hormones, vaccines, and others. Based on expression system, the market is divided into mammalian expression system, E.coli expression system, yeast expression system, and others. Based on end user, the market is divided into academic & research institutions, biotechnology & pharmaceutical companies, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising demand for animal free recombinant cell culture supplements in the country.
Market Players
Abcam plc., Corning Incorporated, BBI Solutions OEM Limited, FUJIFILM Irvine Scientific, Inc., Gemini Bioproducts, LLC, HiMedia Laboratories, LLC, Kingfisher Biotech, Inc., Lonza Group AG, Merck KGaA, and Novus Biologicals, LLC are some of the leading companies operating in the market.
Report Scope:
In this report, global recombinant cell culture supplements market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Recombinant Cell Culture Supplements Market, By Product:
o Recombinant Albumin
o Recombinant Insulin
o Recombinant Epidermal Growth Factors
o Recombinant Transferrin
o Recombinant Trypsin
o Others
- Recombinant Cell Culture Supplements Market, By Application
o Regenerative Medicine
- Stem Cell Therapies
- Cell Therapies
- Gene Therapies
o Bio-Production
- Monoclonal Antibodies
- Recombinant Proteins
- Hormones
- Vaccines
- Others
- Recombinant Cell Culture Supplements Market, By Expression System:
o Mammalian Expression System
o E. coli Expression System
o Yeast Expression System
o Others
- Recombinant Cell Culture Supplements Market, By End User:
o Academic & Research Institutions
o Biotechnology & Pharmaceutical Companies
o Others
- Recombinant Cell Culture Supplements Market, By Region:
o North America
- United States
- Canada
- Mexico
o Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
o Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
o South America
- Brazil
- Argentina
- Colombia
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Recombinant Cell Culture Supplements Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Recombinant Cell Culture Supplements Market
5. Voice of Customer
6. Global Recombinant Cell Culture Supplements Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Recombinant Albumin, Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Transferrin, Recombinant Trypsin, Others)
6.2.2. By Application (Regenerative Medicine v/s Bio-Production)
6.2.2.1. By Regenerative Medicine (Stem Cell Therapies, Cell Therapies, Gene Therapies)
6.2.2.2. By Bio-Production (Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, Others)
6.2.3. By Expression System (Mammalian Expression System, E.Coli Expression System, Yeast Expression System, Others)
6.2.4. By End User (Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Market Map
7. North America Recombinant Cell Culture Supplements Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Recombinant Albumin, Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Transferrin, Recombinant Trypsin, Others)
7.2.2. By Application (Regenerative Medicine v/s Bio-Production)
7.2.2.1. By Regenerative Medicine (Stem Cell Therapies, Cell Therapies, Gene Therapies)
7.2.2.2. By Bio-Production (Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, Others)
7.2.3. By Expression System (Mammalian Expression System, E.Coli Expression System, Yeast Expression System, Others)
7.2.4. By End User (Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others)
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Recombinant Cell Culture Supplements Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Expression System
7.3.1.2.4. By End User
7.3.2. Canada Recombinant Cell Culture Supplements Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Expression System
7.3.2.2.4. By End User
7.3.3. Mexico Recombinant Cell Culture Supplements Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Expression System
7.3.3.2.4. By End User
8. Europe Recombinant Cell Culture Supplements Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Recombinant Albumin, Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Transferrin, Recombinant Trypsin, Others)
8.2.2. By Application (Regenerative Medicine v/s Bio-Production)
8.2.2.1. By Regenerative Medicine (Stem Cell Therapies, Cell Therapies, Gene Therapies)
8.2.2.2. By Bio-Production (Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, Others)
8.2.3. By Expression System (Mammalian Expression System, E.Coli Expression System, Yeast Expression System, Others)
8.2.4. By End User (Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others)
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Recombinant Cell Culture Supplements Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Expression System
8.3.1.2.4. By End User
8.3.2. Germany Recombinant Cell Culture Supplements Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Expression System
8.3.2.2.4. By End User
8.3.3. United Kingdom Recombinant Cell Culture Supplements Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Expression System
8.3.3.2.4. By End User
8.3.4. Italy Recombinant Cell Culture Supplements Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Expression System
8.3.4.2.4. By End User
8.3.5. Spain Recombinant Cell Culture Supplements Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Expression System
8.3.5.2.4. By End User
9. Asia-Pacific Recombinant Cell Culture Supplements Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Recombinant Albumin, Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Transferrin, Recombinant Trypsin, Others)
9.2.2. By Application (Regenerative Medicine v/s Bio-Production)
9.2.2.1. By Regenerative Medicine (Stem Cell Therapies, Cell Therapies, Gene Therapies)
9.2.2.2. By Bio-Production (Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, Others)
9.2.3. By Expression System (Mammalian Expression System, E.Coli Expression System, Yeast Expression System, Others)
9.2.4. By End User (Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others)
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Recombinant Cell Culture Supplements Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Expression System
9.3.1.2.4. By End User
9.3.2. India Recombinant Cell Culture Supplements Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Expression System
9.3.2.2.4. By End User
9.3.3. Japan Recombinant Cell Culture Supplements Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Expression System
9.3.3.2.4. By End User
9.3.4. South Korea Recombinant Cell Culture Supplements Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Application
9.3.4.2.3. By Expression System
9.3.4.2.4. By End User
9.3.5. Australia Recombinant Cell Culture Supplements Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Application
9.3.5.2.3. By Expression System
9.3.5.2.4. By End User
10. South America Recombinant Cell Culture Supplements Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Recombinant Albumin, Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Transferrin, Recombinant Trypsin, Others)
10.2.2. By Application (Regenerative Medicine v/s Bio-Production)
10.2.2.1. By Regenerative Medicine (Stem Cell Therapies, Cell Therapies, Gene Therapies)
10.2.2.2. By Bio-Production (Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, Others)
10.2.3. By Expression System (Mammalian Expression System, E.Coli Expression System, Yeast Expression System, Others)
10.2.4. By End User (Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others)
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Recombinant Cell Culture Supplements Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Expression System
10.3.1.2.4. By End User
10.3.2. Argentina Recombinant Cell Culture Supplements Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Expression System
10.3.2.2.4. By End User
10.3.3. Colombia Recombinant Cell Culture Supplements Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Expression System
10.3.3.2.4. By End User
11. Middle East and Africa Recombinant Cell Culture Supplements Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product (Recombinant Albumin, Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Transferrin, Recombinant Trypsin, Others)
11.2.2. By Application (Regenerative Medicine v/s Bio-Production)
11.2.2.1. By Regenerative Medicine (Stem Cell Therapies, Cell Therapies, Gene Therapies)
11.2.2.2. By Bio-Production (Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, Others)
11.2.3. By Expression System (Mammalian Expression System, E.Coli Expression System, Yeast Expression System, Others)
11.2.4. By End User (Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others)
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Recombinant Cell Culture Supplements Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Application
11.3.1.2.3. By Expression System
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Recombinant Cell Culture Supplements Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Application
11.3.2.2.3. By Expression System
11.3.2.2.4. By End User
11.3.3. UAE Recombinant Cell Culture Supplements Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Application
11.3.3.2.3. By Expression System
11.3.3.2.4. By End User
11.3.4. Turkey Recombinant Cell Culture Supplements Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product
11.3.4.2.2. By Application
11.3.4.2.3. By Expression System
11.3.4.2.4. By End User
11.3.5. Egypt Recombinant Cell Culture Supplements Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Product
11.3.5.2.2. By Application
11.3.5.2.3. By Expression System
11.3.5.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Abcam plc.
14.2. Corning Incorporated
14.3. BBI Solutions OEM Limited
14.4. FUJIFILM Irvine Scientific, Inc.
14.5. Gemini Bioproducts, LLC
14.6. HiMedia Laboratories, LLC
14.7. Kingfisher Biotech, Inc.
14.8. Lonza Group AG
14.9. Merck KGaA
14.10. Novus Biologicals, LLC
15. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security